Use of cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results

APMIS

Volumn 118, Issue 9, 2010, Pages 681-684

  Galan Sanchez, Fatima ^a   Rodriguez Iglesias, Manuel A ^a,b,c  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

HPV; Human papillomavirus; hybrid capture; invader

Indexed keywords

ARTICLE; ASSAY; CERVISTA HPV HR ASSAY; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYBRID CAPTURE METHOD; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; VIRAL GENETICS; VIRUS DETECTION; WART VIRUS;

AGED; ALPHAPAPILLOMAVIRUS; ANIMALS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77955957356     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02639.x     Document Type: Article

References (15)

1. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
2. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001 93 : 293 9.
3. Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 2003 201 : 1 6.
4. Day SP, Hudson A, Mast A, Sander T, Curtis M, Olson S, et al. Analytical performance of the investigational use only Cervista HPV HR test as determined by a multi-center study. J Clin Virol 2009 45 (S1 S63 72.
5. Harvey M, Stout S, Satrhey CR, Hendren R, Holt S, Miller GC. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection. J Clin Virol 2009 45 (S1 S79 83.
6. Ginocchio CC, Barth D, Zhang F. Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the Digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA. J Clin Microbiol 2008 46 : 1641 6.
7. Stillman MJ, Day SP, Schutzbank TE. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus. J Clin Virol 2009 45 (S1 S73 7.
8. Johnson LR, Starkey CR, Palmer J, Taylor J, Stout S, Holt S, et al. A comparison of two methods to determine the presence of high-risk HPV cervical infections. Am J Clin Pathol 2008 130 : 401 8.
9. Schutzbank TE, Jarvis C, Kahmann N, Lopez K, Weimer M, Yount A. Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. J Clin Microbiol 2007 45 : 4067 9.
10. Nobbenhuis MA, Meijer CJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Risse EK, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 2001 84 : 796 801.
11. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N. Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear. J Virol Methods 2008 147 : 10 7.
12. Kulmala SM, Syrjanen S, Shabalova I, Petrovichev N, Kozachenko V, Podistov J, et al. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004 42 : 2470 5.
13. Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, et al. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol 2006 44 : 2141 6.
14. Wong AK, Chan RC, Nichols WS, Bose S. Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay. J Clin Microbiol 2008 46 : 869 75.
15. Franco EL, Cuzick J. Cervical cancer screening following prophylactic human papillomavirus vaccination. Vaccine 2008 26 (Suppl 1 A16 23.